Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 14 Esophageal Neoplasms 9 Melanoma 6 Lung Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 4 Small Cell Lung Carcinoma 4 Esophageal Squamous Cell Carcinoma 4 Colorectal Neoplasms 4 Carcinoma, Hepatocellular 4 Stomach Neoplasms 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Uterine Cervical Neoplasms 2 Neoplasms 2 Nasopharyngeal Carcinoma 2 Carcinoma, Transitional Cell 2 Unresectable Biliary Tract Cancer 1 Thymus Neoplasms 1 Thymoma 1 Thymic epithelial tumor 1 Small Cell Lung Cancer Extensive Stage 1 Recurrence 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pinealoma 1 Pathologic Complete Response 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Nasopharyngeal Neoplasms 1 Muscle-Invasive Bladder Carcinoma 1

Interventions

Temozolomide 16 Irinotecan 13 Cyclophosphamide 11 dinutuximab 9 naxitamab 7 Vincristine 7 Carboplatin 6 sargramostim 5 Melphalan 5 Granulocyte-Macrophage Colony-Stimulating Factor 5 Etoposide 5 fludarabine 4 Topotecan 4 Thiotepa 4 Eflornithine 4 Doxorubicin 4 Cisplatin 4 etoposide phosphate 3 Zoledronic Acid 3 Specimen Handling 3 Isotretinoin 3 Granulocyte Colony-Stimulating Factor 3 saponin QA-21V1 2 lutetium Lu 177 dotatate 2 aldesleukin 2 Vorinostat 2 Stem Cell Transplantation 2 Radiation 2 Platinum 2 Mesna 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neuroblastoma × Immunotherapy × Clear all

NCT06485947 2025-07-08

DBPilot

Princess Maxima Center for Pediatric Oncology

Phase 1 Recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡